![]() |
市場調査レポート
商品コード
1351020
胎児電子心電図(FECG)モニターの世界市場:2023-2030年Global Fetal Electronic Cardiodiagram (FECG) Monitors Market 2023-2030 |
||||||
カスタマイズ可能
|
胎児電子心電図(FECG)モニターの世界市場:2023-2030年 |
出版日: 2023年09月05日
発行: Orion Market Research
ページ情報: 英文 110 Pages
納期: 2~3営業日
|
世界のFECGモニター市場は、予測期間中にCAGR 7.0%の大幅な成長が予測されています。市場拡大を支える主な要因としては、世界中のヘルスケアインフラへの過度な支出とともに、胎児モニタリングとその利点に関する意識の高まりが挙げられます。電子胎児モニタリングは、赤ちゃんの心拍を継続的にモニタリングするもので、陣痛中に赤ちゃんが酸素不足に陥らないようにするため、しばしば使用されます。そのため、ヘルスケアへのアクセスが改善しつつある新興国では、高度なモニタリング機器に対する需要が大幅に増加しています。例えば、2021年2月、インドのビハール州の地区病院におけるモヨ胎児心拍モニター(FHRM)の導入可能性を調査するための研究が実施されました。本研究の目的は、Moyo FHRM導入の障壁と促進要因を明らかにし、産科および新生児転帰データの信頼性を評価することでした。
ポータブルサブセグメントの中でも、据え置き型サブセグメントは予測期間中に大きな成長が見込まれます。この成長の背景には、利便性の高さから病院での採用が増加していることなどがあります。先進医療施設では、据え置き型胎児モニターは胎児の健康状態を継続的にモニタリングするために不可欠なツールです。したがって、アップグレードされ、設備の整った技術的なモニターを統合するためにいくつかの主要なヘルスケア組織を押しました。例えば、2022年。GEヘルスケアはNovii Wireless定置型FECGモニターの提供を開始しました。Novii Wireless Patch Systemは、妊娠中のFHRモニタリングに使用されるFECGモニタリング装置です。胎児の心拍数を分析する非侵襲的な方法を提供し、胎児の成長と健康を示します。新たに導入されたシステムは、胎児心拍数、母体心拍数、子宮活動を非侵襲的に測定・表示する母体・胎児モニターです。
胎児電子心電図(FECG)モニターの世界市場は、北米(米国とカナダ)、欧州(イタリア、スペイン、ドイツ、フランス、その他)、アジア太平洋地域(インド、中国、日本、韓国、その他)、世界のその他の地域(中東とアフリカ、中南米)を含む地理的地域に基づいてさらに区分されます。なかでも欧州市場は、医療インフラが確立していることに加え、先進医療技術の導入が進んでいることから、予測期間中に大幅な成長が見込まれます。一方、アジア太平洋地域は、医療施設の継続的な改善と医療支出の増加により、胎児電子心電図(FECG)モニターの世界市場で大きな成長が見込まれます。
胎児電子心電図(FECG)モニターの世界市場では、北米地域が大きなシェアを占めると予想されます。この地域のFECGモニター市場の成長は、主にヘルスケア診療における胎児モニタリングの比較的高い普及率と高度な医療施設の存在によって強化されています。
Title: Global Fetal Electronic Cardiodiagram (FECG) Monitors Market Size, Share & Trends Analysis Report by Type (Portable and Stationary), by Application (Hospitals, Clinics, and Home Use), by Technology (Direct Contact and Non-contact), and by End-User (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies),Forecast Period (2023-2030).
The global FECG monitors market is projected to grow at a significant CAGR of 7.0% during the forecast period. The primary factor supporting the market expansion includes the rising awareness about fetal monitoring and its benefits along with excessive spending in healthcare infrastructure around the globe. Electronic fetal monitoring continuously monitors a baby's heartbeat, often used during labor to ensure that babies do not lack of oxygen during labor, as it results in brain damage. Consequently, there is a considerable increase in demand for advanced monitoring devices several in emerging economies where healthcare access is improving. For instance, in February 2021, a study was conducted in order to investigate the feasibility of implementing the Moyo fetal heart rate monitor (FHRM) in district hospitals of Bihar state, India. The study aimed to identify the barriers and facilitators for the implementation of Moyo FHRM and assess the reliability of obstetrical and neonatal outcome data.
The global fetal electronic cardiodiagram (FECG) monitors market is categorized based on its type, application, technology, and end-user segments. Based on its type, the market is divided into portable and stationary. When considering the application, the market segments include hospitals, clinics, and home use. Moreover, the market is further divided based on technology which includes direct contact and non-contact categories. Based on the end-user, the market is sub-segmented into hospital pharmacies, retail pharmacies, and online pharmacies. Among the type segment, portable sub-segment is anticipated to capture a substantial market share, owing to its extraordinary convenience of remote operating.
Among the portable sub-segment, the stationary sub-segment is expected to experience significant growth during the forecast period. This growth is attributed to factors including the increased adoption of such monitors in hospital settings owing to its convenience offered. In advanced medical facilities, stationary fetal monitors are essential tools for continuous monitoring of fetal health. Thus, pushed several major healthcare organizations to integrate upgraded and well-equipped technological monitors. For instance, in 2022. GE Healthcare started providing Novii Wireless stationary FECG monitors. The Novii Wireless Patch System is a FECG monitoring device used for monitoring the FHR during pregnancy. They provide a non-invasive method of analyzing the fetal heart rate, indicating the growth and well-being of the fetus. The newly introduced system is a maternal/fetal monitor that non-invasively measures and displays fetal heart rate, maternal heart rate, and uterine activity.
The global fetal electronic cardiodiagram (FECG) monitors market is further segmented based on geographical regions, including North America (the US and Canada), Europe (Italy, Spain, Germany, France, and others), Asia-Pacific (India, China, Japan, South Korea, and others), and the Rest of the World (the Middle East & Africa, and Latin America). Among these, the Europe market is expected to experience substantial growth over the forecast period owing to well-established healthcare infrastructure coupled with the increasing adoption of advanced medical technologies. Meanwhile, the Asia-Pacific region is projected to witness considerable growth in the global fetal electronic cardiodiagram (FECG) monitors market, driven by continuously improving healthcare facilities and rising healthcare spending.
The North American region is expected to hold a significant share in the global fetal electronic cardiodiagram (FECG) monitors market. The regional FECG monitor market growth is primarily bolstering due to a comparatively high prevalence of fetal monitoring in healthcare practices and the presence of advanced medical facilities.
Major companies operating in the global FECG Monitors market include: FUJIFILM Corp., GE HealthCare Technologies Inc., Mindray, Koninklijke Philips N.V., Siemens Healthineers, and others. These market players are actively contributing to market growth through various strategies, including mergers and acquisitions, partnerships, collaborations, funding, and new product launches, in order to maintain their competitiveness in the market. For instance, in July 2021, in partnership with PeriGen, the Texas Children's Pavilion for Women has undertaken a project to implement the PeriWatch Vigilance automated early warning system within a hospital located in Malawi, Africa. This innovative system is designed to consistently monitor maternal and fetal information, aiming to avert potential complications and reduce childbirth-related fatalities.